28
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      CDK9 and H2B Monoubiquitination: A Well-Choreographed Dance

      research-article
      1 , 2 , *
      PLoS Genetics
      Public Library of Science

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Transcriptional regulation in eukaryotes requires the transcriptional machinery to negotiate the complexities of DNA packaged into chromatin. Specific modifications of the core histone proteins serve to regulate transcription and ensure that genes are expressed at the right place and the right time [1]. Not surprisingly, the interaction between the transcriptional apparatus and chromatin is a tango in which the partners are in a close embrace. Cyclin-dependent kinase 9 (CDK9) and its orthologs control both transcription and transcription-coupled chromatin modifications in a variety of species [2], [3]. However, the mechanisms that intertwine CDK9 function with chromatin appear to be distinct in different organisms. A new manuscript in this issue of PLoS Genetics sheds light onto how Cdk9 function is interconnected with the monoubiquitination of histone H2B in the fission yeast Schizosaccharomyces pombe [4]. The Dance Partners: CDK9 and H2Bub1 CDK9 controls transcriptional elongation, transcription-coupled mRNA processing, and histone modification [2], [5]. It accomplishes this by phosphorylating a number of central transcriptional regulatory proteins, including RNA Polymerase II (RNAPII) (reviewed in [6]), Suppressor of Ty-5 (Spt5; or its metazoan ortholog SUPT5H) [7], [8], Rad6 (metazoan UBE2A) [9], [10], and Negative Elongation Factor-E (NELF-E) [11], [12]. Notably, phosphorylation of Ser2 within the repeated YSPTSPS heptapeptide motif of the RNAPII carboxy-terminal domain (CTD) and Thr1 within the Spt5 C-terminal repeat (CTR) are conserved across eukaryotes and responsible for various aspects of CDK9 function. One post-translational histone modification emerging as a key player in numerous processes is histone H2B monoubiquitination (H2Bub1). In mammals this modification appears to serve as an important tumor suppressor [13]. H2Bub1 is associated with the transcribed region of active genes [14], [15] and promotes transcriptional elongation in vitro [16]. Interestingly, the trimethylation of histone H3 lysine 4 (H3K4me3) and lysine 79 (H3K79me3) also depend on H2Bub1 17–19, although its importance to mammalian H3K4me3 may be more limited [20], [21]. New Insights into the CDK9–H2Bub1 Tango The new study by Sansó et al. has unraveled additional details about the complex dance between the fission yeast ortholog of CDK9 (spCdk9, also called Pch1) and H2Bub1 [4]. The authors utilized a genome-wide approach to characterize the effects of a loss of H2Bub1 on RNAPII occupancy and mRNA levels and observed a surprising disconnect: while RNAPII occupancy was significantly impacted at the majority of active genes, only a subset were affected at the mRNA level. In the absence of H2Bub1, RNAPII levels within the transcribed region decreased, and its typical accumulation at the 3′ end of yeast genes was even more pronounced. Consistent with a potential role in transcriptional elongation, Sansó et al. show that H2B monoubiquitination depends on spCdk9 activity, but not on the related RNAPII CTD kinase Lsk1. They further establish that, unlike in human cells [22], [23], this effect is independent of RNAPII CTD phosphorylation and instead requires spCdk9-mediated Spt5 phosphorylation. However, the relationship between CDK9 and H2Bub1 is not a linear pathway. In fact, blocking H2B monoubiquitination by replacing the ubiquitinated lysine in H2B with an arginine (K119R) leads to decreased recruitment of spCdk9 and reduced levels of Spt5 phosphorylation. Does this mean that spCdk9 and H2Bub1 play opposing roles in fission yeast? Phenotypic studies suggest that this may be at least partially true. For example, while H2B K119R mutation or deletion of the S. pombe H2B ubiquitin ligase Brl2 both lead to septation defects, these can be rescued by blocking spCdk9. Furthermore, compound mutants of Spt5 and Set1 suggest that the phenotypic effects of H2Bub1 loss may be due to multifaceted downstream effects of H2Bub1 on both Spt5 (through spCdk9 recruitment) and H3K4me3 (through Set1). Further support for a homeostatic feedback mechanism is provided by studies of RNAPII occupancy in fission yeast with reduced spCdk9 activity. Consistent with opposing roles of H2Bub1 and spCdk9, the authors observed increased RNAPII occupancy in transcribed regions and decreased occupancy at gene 3′ ends. Importantly, the combined mutation of spCdk9 and H2Bub1 rescued the H2B K119R mutation and displayed RNAPII occupancy similar to mutant spCdk9 alone. These results demonstrate the intricacy and complexity of the choreographed tango between CDK9 orthologs and chromatin, and illustrate significant differences between yeast and metazoans. This study shows that although H2Bub1 requires Cdk9 activity in fission yeast, Bur1 in budding yeast [24], and CDK9 in metazoans [5], [9], [20], [22], a different specific mechanism may operate in each species (Figure 1). In both yeasts, Spt5 appears to be the major Bur1/spCdk9 substrate responsible for controlling H2B monoubiquitination, and this occurs in a RNAPII CTD–independent manner [4], [8]. In human cells the situation appears more complex and involves the parallel effects of CDK9-dependent phosphorylation of the RNAPII CTD [20], [22], [23], as well as UBE2A [9] and probably also SUPT5H in some systems [5], [25]. The Sansó et al. study thus underscores the complexity of CDK9 function and the tight bilateral communication between chromatin and transcription. Further analyses will be necessary to address the various differences in CDK9 function in yeast and metazoans. For example, the existence of NELF-E and the prevalence of promoter proximal RNAPII pausing in metazoans likely represent key transcriptional elongation regulatory mechanisms that yeast lack. Furthermore, two additional closely related CDK9 orthologs, CDK12/CRKRS and CDK13/CDC2L5, have been identified and implicated in metazoan transcriptional elongation [26], [27]. Thus, determining the functions of the various CDK9 orthologs and identifying their substrates, and the interaction of these substrates with H2Bub1 and other chromatin modifications, represents an important challenge. 10.1371/journal.pgen.1002860.g001 Figure 1 Interconnections between CDK9 orthologs, their substrates, and downstream histone modifications in yeast and humans. The CDK9 orthologs Bur1 in budding yeast (S. cerevisiae) and spCdk9 in fission yeast (S. pombe) are most closely related to human CDK9, while Ctk1 and Lsk1 are most homologous to CDK12 and 13. (A, B) In yeast the primary Ser2 RNAPII CTD kinases are Ctk1 and Lsk1. Furthermore, Spt5 phosphorylation, rather than Ser2 phosphorylation, is essential for H2Bub1 and its downstream histone modifications H3K4me3 and H3K79me. (C) In metazoans the separation of Ser2 and SUPT5H phosphorylation is less clear. Moreover, Ser2 phosphorylation is required for H2Bub1.

          Related collections

          Most cited references16

          • Record: found
          • Abstract: found
          • Article: not found

          Controlling the elongation phase of transcription with P-TEFb.

          The positive transcription elongation factor b (P-TEFb) is a cyclin-dependent kinase that controls the elongation phase of transcription by RNA polymerase II (RNAPII). This process is made possible by the reversal of effects of negative elongation factors that include NELF and DSIF. In complex organisms, elongation control is critical for the regulated expression of most genes. In those organisms, the function of P-TEFb is influenced negatively by HEXIM proteins and 7SK snRNA and positively by a variety of recruiting factors. Phylogenetic analyses of the components of the human elongation control machinery indicate that the number of mechanisms utilized to regulate P-TEFb function increased as organisms developed more complex developmental patterns.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1.

            Drosophila contains one (dCDK12) and humans contain two (hCDK12 and hCDK13) proteins that are the closest evolutionary relatives of yeast Ctk1, the catalytic subunit of the major elongation-phase C-terminal repeat domain (CTD) kinase in Saccharomyces cerevisiae, CTDK-I. However, until now, neither CDK12 nor CDK13 has been demonstrated to be a bona fide CTD kinase. Using Drosophila, we demonstrate that dCDK12 (CG7597) is a transcription-associated CTD kinase, the ortholog of yCtk1. Fluorescence microscopy reveals that the distribution of dCDK12 on formaldehyde-fixed polytene chromosomes is virtually identical to that of hyperphosphorylated RNA polymerase II (RNAPII), but is distinct from that of P-TEFb (dCDK9 + dCyclin T). Chromatin immunoprecipitation (ChIP) experiments confirm that dCDK12 is present on the transcribed regions of active Drosophila genes. Compared with P-TEFb, dCDK12 amounts are lower at the 5' end and higher in the middle and at the 3' end of genes (both normalized to RNAPII). Appropriately, Drosophila dCDK12 purified from nuclear extracts manifests CTD kinase activity in vitro. Intriguingly, we find that cyclin K is associated with purified dCDK12, implicating it as the cyclin subunit of this CTD kinase. Most importantly, we demonstrate that RNAi knockdown of dCDK12 in S2 cells alters the phosphorylation state of the CTD, reducing its Ser2 phosphorylation levels. Similarly, in human HeLa cells, we show that hCDK13 purified from nuclear extracts displays CTD kinase activity in vitro, as anticipated. Also, we find that chimeric (yeast/human) versions of Ctk1 containing the kinase homology domains of hCDK12/13 (or hCDK9) are functional in yeast cells (and also in vitro); using this system, we show that a bur1(ts) mutant is rescued more efficiently by a hCDK9 chimera than by a hCDK13 chimera, suggesting the following orthology relationships: Bur1 ↔ CDK9 and Ctk1 ↔ CDK12/13. Finally, we show that siRNA knockdown of hCDK12 in HeLa cells results in alterations in the CTD phosphorylation state. Our findings demonstrate that metazoan CDK12 and CDK13 are CTD kinases, and that CDK12 is orthologous to yeast Ctk1.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              P-TEFb-mediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription elongation.

              Human DSIF, a heterodimer composed of hSpt4 and hSpt5, plays opposing roles in transcription elongation by RNA polymerase II (RNA Pol II). Here, we describe an evolutionarily conserved repetitive heptapeptide motif (consensus = G-S-R/Q-T-P) in the C-terminal region (CTR) of hSpt5, which, like the C-terminal domain (CTD) of RNA Pol II, is highly phosphorylated by P-TEFb. Thr-4 residues of the CTR repeats are functionally important phosphorylation sites. In vitro, Thr-4 phosphorylation is critical for the elongation activation activity of DSIF, but not to its elongation repression activity. In vivo, Thr-4 phosphorylation is critical for epidermal growth factor (EGF)-inducible transcription of c-fos and for efficient progression of RNA Pol II along the gene. We consider this phosphorylation to be a switch that converts DSIF from a repressor to an activator. We propose the "mini-CTD" hypothesis, in which phosphorylated CTR is thought to function in a manner analogous to phosphorylated CTD, serving as an additional code for active elongation complexes.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS Genet
                PLoS Genet
                plos
                plosgen
                PLoS Genetics
                Public Library of Science (San Francisco, USA )
                1553-7390
                1553-7404
                August 2012
                August 2012
                2 August 2012
                : 8
                : 8
                : e1002860
                Affiliations
                [1 ]Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
                [2 ]Department of Molecular Oncology, University of Göttingen Medical Center, Göttingen, Germany
                Albert Einstein College of Medicine, United States of America
                Author notes

                The author has declared that no competing interests exist.

                Article
                PGENETICS-D-12-01498
                10.1371/journal.pgen.1002860
                3410825
                22876198
                aa046994-c686-4fa2-a74f-4ffac3c6d383
                Copyright @ 2012

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                Page count
                Pages: 3
                Funding
                Work in the Johnsen group is supported by the German Academic Exchange (DAAD); the EURINDIA Erasmus Mundus External Cooperation Window; the State of Lower Saxony, Hannover, Germany (VWZN2562); the German Research Foundation (DFG; JO 815/1 and GRK1034); and the Deutsche Krebshilfe (109088). The funders had no role in the preparation of the article.
                Categories
                Perspective
                Biology
                Genetics
                Epigenetics
                Gene Expression
                Molecular Cell Biology
                Gene Expression

                Genetics
                Genetics

                Comments

                Comment on this article